Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspar for Marijuana Dependence
NCT00875836Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buspirone in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Primary endpoint: Percent Marijuana-negative Urine Drug Screens at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
buspirone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00875836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00875836.